BioSpace News Archive

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its previously announced concurrent underwritten public offerings of (i) 8,667,333 shares of its common stock and accompanying Class A warrants to purchase up to 1,951,844 shares of its common stock, at a combined price to the public of $7.50 per common share

Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today reported financial results for its second quarter of fiscal year 2019, the period ended February 28, 2019 (2QFY19).

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2019 following the close of market on Thursday, April 25, 2019.

Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it will release financial results for the third quarter of fiscal year 2019 ended March 31, 2019, before the market open on Tuesday, May 7, 2019.

Community Healthcare Trust Incorporated announced that on Tuesday evening, May 7, 2019, after the market closes, it will report results for the first quarter of 2019.

Stress creates risk, maternal education provides resilience

Pomerantz LLP is investigating claims on behalf of investors of Merrimack Pharmaceuticals, Inc..

Pomerantz LLP announces that a class action lawsuit has been filed against Healthcare Services Group, Inc. and certain of its officers.

Pomerantz LLP announces that a class action lawsuit has been filed against Inogen, Inc. and certain of its officers and directors.

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O’Bryan-Tear has joined Clarity’s Board following his recent appointment to their Scientific Advisory Board in August 2018.